• |

Mar. 18, 2015

Ceresney, Focusing on Pharma, Discusses SEC Enforcement Priorities and Compliance Expectations

  • Rebecca Hughes Parker
    Anti-Corruption Report
Andrew Ceresney, the SEC’s Director of Enforcement, recently reaffirmed the SEC’s emphasis on cooperation and self-reporting and highlighted three pharmaceutical company practices that have led to FCPA enforcement actions.  Speaking at CBI’s Pharmaceutical Compliance Congress in Washington, D.C., Ceresney, like others before him, emphasized the benefits of self-reporting.  See also “Top FCPA Officials Talk Compliance Tips and the Defense Bar Weighs In” (Dec. 17, 2014).

To read the full article

Continue reading your article with an ACR subscription.

Most-Read Articles

Spotlight on Trailblazing Women

To mark International Women’s Day 2024, women editors and reporters of ION Analytics interviewed outstanding women in the industries and jurisdictions we cover. In this part, Jill Abitbol, Managing Editor of the Cybersecurity Law Report and Anti-Corruption Report, features notable women in data privacy, cybersecurity, white collar defense, compliance and anti-corruption law, including Christina Montgomery, Leslie Shanklin, Palmina Fava, Alexandra Ross and Lucinda Low. Enjoy reading their inspiring remarks here.